The University of South Florida has named Stephen Liggett its new vice dean for personalized medicine and genomics. Additionally, Liggett will be the associate VP for personalized medicine at the USF Morsani College of Medicine and be the director of the university's Personalized Medicine Institute.
Liggett comes to USF from the University of Maryland School of Medicine, where he was associate dean for interdisciplinary research and director of the cardiopulmonary genomics program.
Douglas Kell has been reappointed as chief executive and deputy chair of the UK Biotechnology and Biological Sciences Research Council.
Kell has held the top post at BBSRC since 2008, and before that he was director of the Manchester Center for Integrative Systems Biology. He also has served as director of research at the Institute of Biological Sciences at the University of Aberystwyth, and he was a founding director of Aber Instruments.
The Institute for Systems Biology has appointed Robert Lipshutz to be chief business officer and senior VP for strategic partnerships. Lipshutz spent nearly two decades at Affymetrix in various roles focusing on business development, licensing, diagnostics, and emerging markets, and most recently as senior VP for corporate development.